Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
Nawal Al Kaabi, Yuntao Zhang, Shengli Xia, et al.
JAMA (2021)
Open Access | Times Cited: 759

Showing 1-25 of 759 citing articles:

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Shuo Feng, Daniel J. Phillips, Thomas White, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2032-2040
Open Access | Times Cited: 1104
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Queenie Fernandes, Varghese Inchakalody, Maysaloun Merhi, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 524-540
Open Access | Times Cited: 372
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Raches Ella, Siddarth Reddy, William C. Blackwelder, et al.
The Lancet (2021) Vol. 398, Iss. 10317, pp. 2173-2184
Open Access | Times Cited: 333
Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 313
Efficacy and safety of COVID-19 vaccines
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, et al.
Cochrane library (2022) Vol. 2023, Iss. 3
Open Access | Times Cited: 254
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 251
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Lauren Forchette, William Sebastian, Tuoen Liu
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1037-1051
Open Access | Times Cited: 224
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2097-2111
Open Access | Times Cited: 222
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
Victoria Rotshild, Bruria Hirsh Raccah, Ian Miskin, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 217
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
Shengli Xia, Yuntao Zhang, Yanxia Wang, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 196-208
Open Access | Times Cited: 178
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
SARS-CoV-2-specific T cells in infection and vaccination
Antonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2307-2312
Open Access | Times Cited: 150
Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet Regional Health - Europe (2021) Vol. 11, pp. 100249-100249
Open Access | Times Cited: 146
Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys
Jingyi Xiao, Justin Cheung, Peng Wu, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 23, pp. 100441-100441
Open Access | Times Cited: 140
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
Wing Ying Au, Peter Pak‐Hang Cheung
BMJ (2022), pp. e069989-e069989
Open Access | Times Cited: 126
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Yihao Liu, Qin Zeng, Caiguanxi Deng, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 122
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 3, pp. 398-404
Open Access | Times Cited: 120
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
Qiaoli Peng, Runhong Zhou, Yuewen Wang, et al.
EBioMedicine (2022) Vol. 77, pp. 103904-103904
Open Access | Times Cited: 113
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
Yujing Fan, Kwok‐Hung Chan, Ivan Fan‐Ngai Hung
Vaccines (2021) Vol. 9, Iss. 9, pp. 989-989
Open Access | Times Cited: 109
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
Science Bulletin (2022) Vol. 67, Iss. 13, pp. 1372-1387
Open Access | Times Cited: 100
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98
Long COVID: An inevitable sequela of SARS-CoV-2 infection
Chih‐Cheng Lai, Chi‐Kuei Hsu, Muh‐Yong Yen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 1, pp. 1-9
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top